| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |